|
 |
Home
|
|
 |
|
Director's Letter
|
|
|
History of the Program and Accomplishments
|
|
|
Description of the Program
|
|
|
Resources and Environment
|
|
|
Children's Hospital
|
|
|
Basic Research Faculty
|
|
|
GI Cell Biology Laboratories
|
|
|
Harvard Digestive Diseases Center
|
|
|
Graduate Programs at Harvard & MIT
|
|
|
Clinical Research Faculty
|
|
|
|
Afdhal, Nezam H.
|
|
|
|
Austin, S. Bryn
|
|
|
|
Christiani, David C.
|
|
|
|
Cook, E. Francis
|
|
|
|
Duggan, Christopher P.
|
|
|
|
Fawzi, Wafaie W.
|
|
|
|
Finkelstein, Jonathan A.
|
|
|
|
Gillman, Matthew W.
|
|
|
|
Goldmann, Donald A.
|
|
|
|
Gordon, Catherine M.
|
|
|
|
Grand, Richard J.
|
|
|
|
Grinspoon, Steven K.
|
|
|
|
Jaksic, Tom
|
|
|
|
Klibanski, Anne
|
|
|
|
Lightdale, Jenifer R.
|
|
|
|
Ludwig, David S.
|
|
|
|
Newburger, Jane W.
|
|
|
|
Nurko, Samuel S.
|
|
|
|
Osganian, Stavroula K.
|
|
|
|
Rufo, Paul A.
|
|
|
|
Sands, Bruce E.
|
|
|
|
Willett, Walter C.
|
|
|
|
Center for Inflammatory Bowel Disease
|
|
|
Master Degree Programs in Clinical Research
|
|
|
General Clinical Research Centers
|
|
|
Current Fellows
|
|
|
Alumni
|
|
|
Application Process and Forms
|
|
|
Benefits
|
|
|
Program Materials
|
|
|
|
|
|
Bruce E. Sands, MD, SM
|
|
Co-Director, Inflammatory Bowel Disease Center, Massachusetts General Hospital
|
|
|
Gastroenterology Associates
55 Fruit Street, BLK 4
Boston, MA 02114-2696
Phone: 617-724-6005
Email: bsands@partners.org
|
|
|
Research Interests
Dr. Sand's interests are in clinical trials of novel therapeutic agents and modalities for Crohn's disease and ulcerative colitis; genotype-phenotype correlations in IBD; validation of disease/treatment outcomes in IBD; prognostic factors in the clinical course of Crohn's disease; pharmacoepidemiology
Selected Publications
Rutgeerts P, Sandborn WJ, Feagan BG, Reinisch W, Olson A, Johanns J, Travers S, Rachmilewitz D, Hanauer SB, Lichtenstein GR, de Villiers WJ, Present D, Sands BE, Colombel JF. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2005;353(23):2462-76.
Lichtenstein GR, Yan S, Bala M, Blank M, Sands BE. Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease. Gastroenterology. 2005;128(4):862-9.
Sands BE, Anderson FH, Bernstein CN, Chey WY, Feagan BG, Fedorak RN, Kamm MA, Korzenik JR, Lashner BA, Onken JE, Rachmilewitz D, Rutgeerts P, Wild G, Wolf DC, Marsters PA, Travers SB, Blank MA, van Deventer SJ. Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med. 2004;350(9):876-85.
|
|
|
|
|
|
|
